Does PACLITAXEL Cause Myelosuppression? 2,522 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,522 reports of Myelosuppression have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 3.3% of all adverse event reports for PACLITAXEL.
2,522
Reports of Myelosuppression with PACLITAXEL
3.3%
of all PACLITAXEL reports
48
Deaths
1,127
Hospitalizations
How Dangerous Is Myelosuppression From PACLITAXEL?
Of the 2,522 reports, 48 (1.9%) resulted in death, 1,127 (44.7%) required hospitalization, and 167 (6.6%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for PACLITAXEL.
What Other Side Effects Does PACLITAXEL Cause?
Neutropenia (4,553)
Nausea (4,521)
Dyspnoea (4,519)
Diarrhoea (4,289)
Off label use (4,075)
Anaemia (3,949)
Neuropathy peripheral (3,508)
Malignant neoplasm progression (3,484)
Fatigue (3,418)
Death (3,143)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
METHOTREXATE (1,523)
Which PACLITAXEL Alternatives Have Lower Myelosuppression Risk?
PACLITAXEL vs PACRITINIB
PACLITAXEL vs PALBOCICLIB
PACLITAXEL vs PALIPERIDONE
PACLITAXEL vs PALIVIZUMAB
PACLITAXEL vs PALONOSETRON